Status
ACTIVE
Global HQ 
Manchester, United Kingdom
 Countries of investment 
- United Kingdom
Investment stages
- Seed
- Series A
Industries 
- MedTech
- Biotechnology
About
The GM&C Life Sciences Fund is dedicated to supporting life-science startups in North-West England, particularly those with translational potential—meaning the ability to move from research and development into real-world applications. This fund focuses on sectors such as medtech, diagnostics, and therapeutics, and prioritizes ventures that have credible clinical development paths. With a focus on capital efficiency and long-term growth, the GM&C Life Sciences Fund aims to help these companies reach the market and become leaders in their fields.
The GM&C Life Sciences Fund is dedicated to supporting life-science startups in North-West England, particularly those with translational potential—meaning the ability to move from research and development into real-world applications. This fund focuses on sectors such as medtech, diagnostics, and therapeutics, and prioritizes ventures that have credible clinical development paths. With a focus on capital efficiency and long-term growth, the GM&C Life Sciences Fund aims to help these companies reach the market and become leaders in their fields.
 Investment Thesis  
GM&C Life Sciences Fund’s thesis is to back innovative life-science companies in North-West England that demonstrate translational and commercial potential. It targets early-stage ventures with robust R&D pipelines, credible management, and scalable technologies in medtech, therapeutics, and diagnostics. The fund aims to catalyze regional innovation by helping companies bridge the gap between research and clinical or market application.
Manager's Experience
Managed by industry veterans with deep expertise in life sciences and healthcare investing, combining scientific and commercial backgrounds to support biotech innovation.
 Team
Duncan Cameron – Investment Director
Professor Rob Carroll – Director
Dr. Tony Flinn – Partner
Kevin D'Silva – Senior Advisor
Dr. Gareth King – Senior Advisor
Laurence Vaughan – Chief Technology Officer
Dr. David Whitcombe – Senior Advisor
Nick Wright – Investment Director
Sarah Cooper – Portfolio Manager
Anne Freeman – Senior Advisor
Corinne Lawrence – Senior Associate
Natalie Melvin – Associate
Hamish Graham – Partner.